Charts

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced that it entered into a Materials Transfer Agreement (MTA) with Santersus AG, a Zurich-London based, privately held therapeutic medical device company, for Santersus' NucleoCapture and HemoNucleoCapture devices.

Aethlon Medical, Inc. (NASDAQ:AEMD) Q3 2024 Earnings Call Transcript February 14, 2024 Aethlon Medical, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and welcome to the Aethlon Medical Third Quarter Fiscal 2024 Earnings and Corporate Update. [Operator […]

By M. Marin NASDAQ:AEMD Moving forward towards oncology clinical studies in India & Australia Aethlon Medical (NASDAQ:AEMD) reported 3Q F24 results yesterday and provided a business update, as the company continues to advance research and clinical development activities for medical device, the Hemopurifier®. Under interim CEO James Frakes, the company’s long-standing CFO, AEMD has increased

Aethlon Medical (NASDAQ:AEMD) reported its Q3 earnings results on Wednesday, February 14, 2024 at 04:15 PM. Here's what investors need ...

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today reported financial results for its fiscal third quarter ended December 31, 2023 and provided an update on recent developments.

Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is projected to report quarterly earnings at $1.65 per share on ...

Aethlon Medical (NASDAQ:AEMD) is set to give its latest quarterly earnings report on Wednesday, 2024-02-14. Here's what investors need ...

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, today announced that it will issue financial results for its fiscal third quarter ended December 31, 2023, at 4:15 p.m. ET on Wednesday, February 14, 2024.

Gainers MSP Recovery (NASDAQ:LIFW) shares rose 23.1% to $1.49 during Monday's pre-market session. The market value of their outstanding ...

Gainers Telesis Bio (NASDAQ:TBIO) shares moved upwards by 32.5% to $0.53 during Friday's pre-market session. The company's market cap ...

Shares of Faraday Future Intelligent Electric Inc. (NASDAQ: FFIE) surged in pre-market trading after the company announced its foray ...

By M. Marin NASDAQ:AEMD READ THE FULL AEMD RESEARCH REPORT Expect no disruption from management change; increased emphasis on studying Hemopurifier® in oncology likely… Aethlon Medical (NASDAQ:AEMD) appointed CFO James Frakes as interim CEO. We expect no disruption as a result of the management change – Mr. Frakes has been with Aethlon since 2008 & knows the company well, in our view.

Aethlon Medical, Inc. (NASDAQ:AEMD) Q2 2024 Earnings Call Transcript November 14, 2023 Operator: Good day, and welcome to the Aethlon Medical Second Quarter Fiscal 2024 Earnings and Corporate Update Call. [Operator Instructions]. Please note this event is being recorded. I would now like to turn the conference over to Mr. Michael Miller with Rx Communications. […]

Aethlon Medical (NASDAQ:AEMD) reported its Q2 earnings results on Tuesday, November 14, 2023 at 04:15 PM. Here's what investors need to ...

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, today reported financial results for its fiscal second quarter ended September 30, 2023 and provided an update on recent developments.

Aethlon Medical (NASDAQ:AEMD) is set to give its latest quarterly earnings report on Tuesday, 2023-11-14. Here's what investors need to ...

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, today announced that James B. Frakes, M.B.A., Chief Financial Officer of the Company, was appointed as Interim Chief Executive Officer, replacing Charles J. Fisher, Jr. M.D. Mr. Frakes also was appointed as a member of the Board of Directors and will remain as Chief Financial Officer of the Company. Additionally, Guy Cipriani, formerly Chief

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening viral infections and for use in organ transplantation, today announced that it will issue financial results for its second quarter ended September 30, 2023, at 4:15 p.m. ET on Tuesday, November 14, 2023.

By M. Marin NASDAQ:AEMD READ THE FULL AEMD RESEARCH REPORT Clearance from India’s drug authority advances goal to study Hemopurifier® in patients with solid tumors Aethlon Medical (NASDAQ:AEMD) has received clearance from India’s central drug authority to conduct a phase 1 trial of the Hemopurifier® in patients being treated with checkpoint inhibitor therapy. Despite the many benefits of

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening viral infections and for use in organ transplantation, today announced that it has received clearance from the Drug Controller General of India (DCGI), the central drug authority in India, to conduct a phase 1 safety, feasibility and dose-finding trial of the company's Hemopurifier® in patients with solid tumors who have stable or progressive disease during anti

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, today announced that its Board of Directors has approved a 1-for-10 reverse stock split of the Company's common stock, effective at 5:00 p.m. ET on October 4, 2023. The Company's shares of common stock will begin trading on a reverse split-adjusted basis commencing upon market opening on October 5, 2023.

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, today announced that Steven LaRosa, M.D., Chief Medical Officer, and James Frakes, Chief Financial Officer, will present a company overview on Tuesday, September 12 at 4:30 PM EST, during the H.C. Wainwright 25th Annual Global Investment Conference taking place September 11-13, 2023, in New York City.

By M. Marin NASDAQ:AEMD READ THE FULL AEMD RESEARCH REPORT R&D spending expected to go further by conducting current clinical efforts in Australia & India Aethlon Medical (NASDAQ:AEMD) is studying its lead product, the Hemopurifier®, in oncology, infectious disease and, reflecting a recent initiative, to determine the device’s ability to improve the outcomes of organ transplantation. AEMD

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, today reported financial results for its fiscal first quarter ended June 30, 2023 and provided an update on recent developments.

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced that it will issue financial results for its first quarter ended June 30, 2023, at 4:15 p.m. EST on Thursday, August 10, 2023.

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced that it has signed a Collaboration Agreement with 34 Lives, PBC, to investigate the use of Aethlon's proprietary Hemopurifier® technology and 34 Lives' organ evaluation and preservation system, with the goal of increasing the supply of useable donated kidneys for human transplant. Financial terms of the agreement were not dis

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, today announced the appointment of Nicolas Gikakis to its Board of Directors (Board), effective July 3, 2023. Mr. Gikakis will also serve as a member of the Nominating and Corporate Governance Committee of the Board. In connection with the appointment of Mr. Gikakis as a director, the authorized size of Aethlon Medical's Board was increased

Gainers Caribou Biosciences (NASDAQ:CRBU) stock rose 50.7% to $6.15 during Thursday's regular session. The current volume of 75.4 ...

By M. Marin NASDAQ:AEMD READ THE FULL AEMD RESEARCH REPORT Strengthening team with recently added CSO & new board member… Aethlon Medical (NASDAQ:AEMD) has strengthened its team with the recent addition of a new CSO (Chief Scientific Officer) and new board member. Moreover, the company continues to focus on maximizing R&D spending in order to advance the Aethlon Hemopurifier®, its lead

Gainers Caribou Biosciences, Inc. (NASDAQ: CRBU) shares jumped 58.1% to $6.45 after the company announced a $25 million equity ...

Gainers Incannex Healthcare (NASDAQ:IXHL) stock rose 32.2% to $2.46 during Thursday's pre-market session. The market value of their ...

Companies Reporting Before The Bell • General Mills (NYSE:GIS) is estimated to report quarterly earnings at $1.07 per share on ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Pre-market stock movers are a hot topic with traders on Thursday as we go over the shares seeing the biggest movements this morning. The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live Wall Street Titan: Here’s My #1 Stock for 2023 The $1 Investment You MUST Take Advantage of Right Now It doesn’t matter if you have $500 or $5 million. Do this now.

Gainers Aditxt, Inc. (NASDAQ: ADTX) shares gained 68.6% to $1.45. Aditxt signed asset purchase agreement to acquire 50% ownership ...

Companies Reporting Before The Bell • EuroDry (NASDAQ:EDRY) is expected to report quarterly earnings at $2.68 per share on ...

Aethlon Medical (NASDAQ:AEMD) is set to give its latest quarterly earnings report on Monday, 2023-02-13. Here's what investors need to ...

Gainers Bright Green (NASDAQ:BGXX) shares increased by 251.2% to $1.83 during Wednesday's regular session. The current volume of 81.8 ...

Gainers Motorsport Games Inc. (NASDAQ: MSGM) shares jumped 770% to $22.99. The company announced a debt-for-equity exchange with ...

Gainers Motorsport Games Inc. (NASDAQ: MSGM) shares rose 131.8% to $6.12 in pre-market trading. Motorsport Games entered into a ...

Gainers Hillstream BioPharma (NASDAQ:HILS) stock rose 131.0% to $1.55 during Tuesday's pre-market session. The company's market cap ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Investors can get ready for another busy day of trading with a breakdown of the biggest pre-market stock movers for Tuesday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today It doesn’t matter if you have $500 or $5 million. Do this now. Massive Bear Market “Divergence Event” Ahead… And The #1 Way to Play It

Gainers Heart Test Laboratories, Inc. (NASDAQ: HSCS) shares surged 136% to $2.06 after Ascendant Capital initiated coverage on the ...

Gainers Heart Test Laboratories (NASDAQ:HSCS) stock rose 127.6% to $1.98 during Monday's regular session. As of 12:30 EST, this ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips AEMD stock traders are weighing Aethlon Medical's partnership with an organization that could help it advance an important medical product. The post Why Is Aethlon Medical (AEMD) Stock Up 50% Today? appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today It doesn’t matter if you have $500 or $5 million. Do this now. Massive Bear Market “Divergence Event” Ahead… And The #1 Way to Play It

Gainers Hepion Pharmaceuticals (NASDAQ:HEPA) stock increased by 72.2% to $0.79 during Tuesday's after-market session. At the close, ...

Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 133% to $0.3218. Swvl recently announced the commencement of a strategic review ...

Gainers Spruce Biosciences (NASDAQ:SPRB) stock increased by 85.6% to $2.32 during Friday's regular session. The current volume of 54.1 ...

Gainers OncoCyte Corporation (NASDAQ: OCX) rose 89.2% to $0.70 in pre-market trading. Oncocyte, last month, announced an over 40% ...

Gainers Spruce Biosciences (NASDAQ:SPRB) stock moved upwards by 57.6% to $1.97 during Thursday's after-market session. This security ...

Gainers Gorilla Technology Group Inc. (NASDAQ: GRRR) shares rose 162% to $21.30 in pre-market trading after jumping over 35% on ...

Gainers Cardio Diagnostics Hldgs (NASDAQ:CDIO) shares moved upwards by 41.7% to $1.46 during Friday's after-market session. The ...

Gainers Aethlon Medical (NASDAQ:AEMD) shares increased by 16.4% to $0.52 during Wednesday's after-market session. At the close, Aethlon ...

On Wednesday, 70 companies set new 52-week lows. Noteworthy Mentions In Today's 52-Week Lows: The largest company ...

Researchers have warned that a dangerous monkeypox variant with a fatality rate as high as 10% is circulating in Central Africa, ...

During Friday, 125 stocks hit new 52-week lows. Things to Consider About Today's 52-Week Lows: Amazon.com ...

According to the World Health Organization, health officials arewitnessing early signsthat the new monkeypox case growth ...

Gainers BioAtla, Inc. (NASDAQ: BCAB) gained 50.1% to $5.42 following Q2 results. Euro Tech Holdings Company Limited (NASDAQ: ...

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Vir Biotech Shuns FDA ...

Gainers T2 Biosystems (NASDAQ:TTOO) shares increased by 15.45% to $0.14. The company's market cap stands ...

Aethlon Medical Inc(NASDAQ: AEMD)said it is commissioninga newin vitrobinding experiment to confirm ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips It's time for another dive into the biggest pre-market stock movers as we check out the latest news for Wednesday morning! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” It doesn’t matter if you have $500 or $5 million. Do this now.

Gainers ObsEva SA (NASDAQ: OBSV) shares rose 33.8% to $0.4080 in pre-market trading. ObsEva recently announced a $31 million debt ...

Aethlon Medical (NASDAQ:AEMD) reported its Q1 earnings results on Tuesday, August 9, 2022 at 04:15 PM. Here's what ...